Bringing cell and gene therapy (CGT) products to market is not without its challenges. In this roundtable discussion, experts will discuss how to overcome these hurdles in cell and gene process development and manufacturing and how this can help biotech companies on their way to commercial readiness.
Learn from experts discussing critical factors and solutions related to scalability, process optimization, automation and compliance, and quality assurance.
Webinar learning objectives
Better understanding of the ecosystem/valley of uncertainties when transitioning from early drug discovery phases towards commercial CMC (chemistry, manufacturing, and controls) preparedness.
Learn how CMC platform technologies can help to keep flexibility throughout the process discovery phase while ultimately delivering robustness towards clinical & commercial manufacturing.
Learn how to ensure scalability and consistency beyond manufacturing & QC when transitioning from small-scale to commercial-scale production
Understand key supply chain parameter and how to manage a commercial ramp-up successfully.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
